Peripheral artery disease

New - Data from the Imperial Clinical Program demonstrates ELUVIA moreeffective in diabetic patients  January 22, 2019    

Boston Scientific today announced diabetic
subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of...

READ MORE

Boston Scientific Announces Favorable Twelve-Month Data for Ranger™ Paclitaxel-Coated PTA Balloon Catheter - April 25, 2017

Boston Scientific today announced results from the RANGER SFA trial for the Ranger™ Paclitaxel-Coated PTA Balloon Catheter at the ...

READ MORE

SEE ALL PRESS RELEASES

2017 | 2016 | 2015

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com

Company Profile
Top